03.02.2023 14:01:14
|
Twist Bioscience Corp Q1 Loss decreases, beats estimates
(RTTNews) - Twist Bioscience Corp (TWST) reported Loss for first quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line totaled -$41.814 million, or -$0.74 per share. This compares with -$45.563 million, or -$0.91 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$1.13 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 29.1% to $54.243 million from $42.018 million last year.
Twist Bioscience Corp earnings at a glance (GAAP) :
-Earnings (Q1): -$41.814 Mln. vs. -$45.563 Mln. last year. -EPS (Q1): -$0.74 vs. -$0.91 last year. -Analyst Estimates: -$1.13 -Revenue (Q1): $54.243 Mln vs. $42.018 Mln last year.
-Guidance: Full year revenue guidance: $261 Mln to $269 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Twist Bioscience Corporation Registered Shsmehr Nachrichten
02.02.25 |
Ausblick: Twist Bioscience präsentiert Quartalsergebnisse (finanzen.net) | |
03.11.24 |
Erste Schätzungen: Twist Bioscience gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Twist Bioscience Corporation Registered Shsmehr Analysen
Aktien in diesem Artikel
Twist Bioscience Corporation Registered Shs | 42,53 | 0,43% |
|